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Rationale: The evidence for an effect of breastfeeding on lung func-
tion is conflicting, in particular whether the effect is modified by
maternal asthma.
Objectives: To explore the association between breastfeeding and
school-age lung function.
Methods: In the Leicestershire Cohort Studies we assessed duration
of breastfeeding (not breastfed, <3 months, 4–6 months, and .6
months), other exposures, and respiratory symptoms by repeated
questionnaires. Post-bronchodilator FVC, FEV1, peak expiratoryflow
(PEF), forced midexpiratory flow (FEF50), and skin prick tests were
measuredat age12years.Weperformedmultivariable linear regres-
sion and tested potential causal pathways (N ¼ 1,458).
Measurements and Main Results: In the entire sample, FEF50 was
higher by 130 and 164 ml in children breastfed for 4 to 6 months
and longer than 6 months, respectively, compared with those not
breastfed (P¼0.048and0.041),with largereffects if themother had
asthma. FVC and FEV1 were associated with breastfeeding only in
children of mothers with asthma (P for interaction, 0.018 and
0.008): FVC was increased by 123 and 164 ml for those breastfed 4
to 6 months or longer than 6 months, respectively (P ¼ 0.177 and
0.040) and FEV1 was increased by 148 and 167 ml, respectively (P ¼
0.050 and 0.016). Results were unchanged after adjustment for re-
spiratory infections in infancy and asthma and atopy in the child.
Conclusions: In this cohort, breastfeeding for more than 4 months
was associatedwith increased FEF50 and, in children ofmotherswith
asthma, with increased FEV1 and FVC. It seems that the effect is not
mediated via avoidance of early infections or atopy but rather
through a direct effect on lung growth.
Keywords: breastfeeding; lung function; epidemiology; maternal
asthma; effect modification
Breastfeeding has numerous advantages for infants, mothers,
and society, including developmental, nutritional, immunologi-
cal, psychological, social, economic, and environmental benefits
(1). The World Health Organization and the American Associ-
ation of Pediatrics therefore recommend exclusive breastfeeding
for 6 months and partial breastfeeding for the first year and be-
yond (2). Less clear is the impact of breastfeeding on respiratory
health. It is generally accepted that breastfed children have fewer
respiratory infections than their nonbreastfed peers and that
these are less severe (3–5).
Few studies have investigated a possible effect of breastfeed-
ing on lung function, with heterogeneous results (see Tables E1
and E2 in the online supplement) (6–11). Most found a higher
FVC or FEV1 in school-age children who had been breastfed (6,
8–11). Results for other lung function measurements were more
discrepant: two studies found higher peak expiratory flow rates
(PEF) in breastfed children (7, 9), one study found no associa-
tion with FEV1/FVC (9), and Guilbert and coauthors reported
decreased FEV1/FVC in breastfed children, particularity in
those whose mothers had asthma, suggesting a detrimental ef-
fect of breastfeeding in this subgroup (6).
Previous studies have suffered from methodological limitations.
These include insufficient adjustment for important confounders,
such as tobacco smoke exposure. Also, important sources of bias
were often not addressed, such as the possibility of reverse causation
(12, 13)—early wheeze leading to prolongation of breastfeeding—
which was addressed in one study only (7). None of the studies
addressed the possible bias introduced by excluding cases with
missing values from the analysis (14, 15). Furthermore, only two
studies (6, 9) investigated in detail a possible effect modification by
maternal history of asthma or atopy.
In this study, we investigated the association between breast-
feeding and lung function at school age in a population-based
cohort of children, adjusting for important confounders and min-
imizing methodological limitations of previous studies. We de-
termined if breastfeeding has differential effects on different
lung function measures, assessed whether associations differed
by any maternal history of asthma, and explored possible path-
ways (early infections and wheezing disorders/atopy) that could
explain our findings (Figure 1). We hypothesized that longer
duration of breastfeeding is associated with increased lung
function values after appropriate adjustment for confounders and
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AT A GLANCE COMMENTARY
Scientific Knowledge on the Subject
The association between breastfeeding and lung function is
a matter of debate, especially in children of mothers with
asthma.
What This Study Adds to the Field
In this cohort, breastfed children of mothers with asthma had
higher FVC, FEV1, and FEF50 compared with nonbreastfed.
Our data suggest a direct effect of breastfeeding on lung
growth.
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reverse causation, but there is no effect modification by maternal
asthma for any outcome. Some of the results of this study have
been previously reported in the form of an abstract (16).
METHODS
More details are provided in the online supplement.
Study Population and Measurements
We analyzed data from a nested sample of 1,458 children born between
1993 and 1997 from the Leicestershire cohorts, described in detail else-
where (17, 18). In short, we recruited a random population-based sam-
ple of 6,808 children of white and south Asian ethnic origin. Perinatal
data were collected at birth, and data on growth and development were
acquired prospectively during childhood. Respiratory morbidity and
individual and family-related exposures were assessed by repeated
questionnaires (1998, 2001, 2003, 2006, 2010). In 2006 to 2010, families
who had returned two or more questionnaires (n ¼ 4,125) were invited
to the laboratory for assessment of lung function by spirometry and
atopic status by skin prick tests. We recorded FVC, FEV1, PEF, and
forced midexpiratory flow (FEF50) before and 15 minutes after ad-
ministering salbutamol 400 mg by spacer. The main outcome was
post-bronchodilator lung function, because it reflects structural lung
development rather than reversible airway obstruction. Skin prick
tests were performed for four allergens (cat hair, dog hair, six-grass
mix, and house dust mite), a positive and a negative control.
Information on total duration of any breastfeeding, categorized as
not breastfed, less than or equal to 3 months, 4 to 6 months, and more
than 6 months, was collected in 1998, when children were aged 1 year
(n ¼ 979) or 2 to 4 years (n ¼ 479). The question has excellent repeat-
ability (Cohen’s kappa ¼ 0.96) (19).
The study was approved by the local Area Health Authority Re-
search Ethics Committee.
Data Analysis
We investigated the association between breastfeeding and lung func-
tion and whether it might be explained by various pathways (Figure
1), using multivariable linear regression models. A complete data anal-
ysis that excludes children with missing data on any variable reduces
the analyzable sample to half (n ¼ 773). To improve statistical power
and minimize possible bias in estimating associations, we used multiple
imputations (14, 15).
Each lung function measure was analyzed in three steps. First, we
adjusted only for anthropometric data (age, height, weight and sex;
baseline model). Second, we adjusted additionally, in the entire sample
and stratified by maternal asthma, for potential confounders (perinatal
data, ethnicity, socioeconomic factors, urban residence, parental history
of asthma, exposure to infections, wheezing during breastfeeding, and
prenatal and postnatal tobacco smoke exposure) as described in the
online supplement and in Table 1 (adjusted model). Third, we included
an interaction term to test for effect modification by maternal asthma
(interaction model).
We performed additional analyses to examine potential sources
of bias: (1a) effect of missing data/multiple imputation, repeating
the analyses for children with complete data; (1b) breastfeeding recall
bias, excluding children with assessment of breastfeeding after age
1 year; (1c) reverse causation, separately excluding children with onset
of wheeze during breastfeeding and during first year; and (1d) effect of
reversible airway obstruction, by looking at prebronchodilator lung
function. We also investigated possible causal pathways between
breastfeeding and lung function: (2a) early respiratory infections in
general and early lower respiratory tract infections in particular, and
(2b) development of atopy and/or asthma. We used Stata 11.2 for
analysis (Stata Corporation, Austin, TX).
RESULTS
Participants
Of the 4,125 children invited for laboratory measurements, 1,477
attended. Among those, 19 had been born extreme preterm
(birth weight , 1,500 g or gestational age , 32 wk) and were
dropped from the analysis, resulting in a final sample of 1,458.
The mean age at lung function measurement was 12.2 years
(range 8.5–14.0 yr). Compared with children not attending the
laboratory, participants with spirometry tended to have been
breastfed for longer, to be white, to have older and better-
educated parents, and to live in affluent areas. They were less
likely to have attended a nursery and less likely to have had
prenatal tobacco smoke exposure but more likely to have been
exposed postnatally (Table E3).
Breastfeeding Prevalence
Overall, 471 children (32%) had not been breastfed at all, 438
(30%) had been breastfed for 3 or fewer months, 213 (15%)
for 4 to 6 months, and 326 (22%) for more than 6 months. (De-
scriptive statistics are based on original values, not imputed ones;
therefore, in all descriptive tables the frequencies do not add up
to the total of 1,458 due to missing values.) Longer duration of
breastfeeding was associated with higher birth weight, higher
Figure 1. Model of the associa-
tion between breastfeeding and
lung function, including poten-
tial confounders and pathways.
It is hypothesized that the varia-
bles in the model have an influ-
ence on lung growth and
development, which, in turn,
impact lung function measure-
ments at school age. *Skin prick
test for cat, dog, grass, dust;
history of severe wheeze. yFre-
quency and duration of colds
during first year; number of
other respiratory infections dur-
ing first year. zSex, age, height, quadratic height, weight, quadratic weight, number of older siblings, nursery use, birth weight, gestational age, birth
season (winter, spring, summer, autumn), wheeze onset during breastfeeding. xMaternal age, maternal ethnicity, family education, maternal asthma,
paternal asthma, Townsend deprivation score (25), residence area (urban or rural). ║Smoking exposure during pregnancy, smoking exposure during
childhood. **Wheezing during breastfeeding is a precursor of wheezing in later life, which can lead to poor lung development and poor lung function
(arrow not shown). However, it could also play a role in reverse causation (when the outcome influences the exposure): poor lung function at school
age may be a direct result of poor lung development in infancy, which may have caused wheezing, which in turn may have influenced the duration of
breastfeeding (dashed line).
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gestational age, older siblings, nursery use, wheezing with onset
during the breastfeeding period, older mothers, south Asian eth-
nicity, better-educated parents, living in affluent area, and less
pre- and postnatal tobacco smoke exposure (Table 1).
Breastfeeding and Lung Function
The complete results of the three models (baseline, adjusted, and
with interaction) for all lung function measures are presented in
Table E4, both for the entire sample and stratified by maternal
asthma. The most pertinent findings are summarized in Table 2,
Table 3, and Figure 2 and are discussed below.
FVC and FEV1. In the entire sample, we did not find evidence
for an association between duration of breastfeeding and post-
bronchodilator FVC or FEV1, either in the baseline model or
after adjustment for potential confounders (Table 2, Table E4).
For FEV1 for instance, the estimated difference compared with
no breastfeeding in the adjusted model was 0.010 L (P ¼ 0.653)
for breastfeeding 3 months or less, 0.012 L (P ¼ 0.674) for
breastfeeding 4 to 6 months, and 0.041 L (P ¼ 0.239) for breast-
feeding more than 6 months (Table E4, adjusted model, entire
sample). When we stratified for maternal asthma, there was
again no evidence for an association between breastfeeding and
FVC or FEV1 in children of mothers without asthma (Table E4,
adjusted model, children of mothers without asthma). Children of
mothers with asthma, however, had significantly higher FVC and
FEV1 if they had been breastfed for 4 months or longer. For
instance: the estimated difference for FEV1 was 0.148 L (P ¼
0.028) for breastfeeding 4 to 6 months and 0.183 L (P¼ 0.019) for
breastfeeding more than 6 months (Table E4, adjusted model,
children of mothers with asthma).
Allowing for effect modification by maternal asthma (Table
3, Figure 2), we found that, if not breastfed, children of mothers
with asthma tended to have a lower FVC (estimated difference
20.080 L, P ¼ 0.062) and FEV1 (estimated difference, 20.095
L; P ¼ 0.011) than children of mothers without asthma. We
found no evidence of association between breastfeeding and
FVC or FEV1 in children of mothers without asthma. However,
in children of mothers with asthma, FEV1 was higher if they
had been breastfed: estimated differences 0.148 L (P ¼ 0.050,
P value for interaction between breastfeeding and maternal
asthma ¼ 0.016) and 0.167 L (P ¼ 0.016, P value for interaction ¼
0.08) for breastfeeding 4 to 6 months and more than 6 months,
respectively. Results for FVC were essentially similar.
TABLE 1. CHARACTERISTICS OF THE STUDY POPULATION
Complete Data*
No BF
(n ¼ 471)
BF < 3 mo
(n ¼ 438)
BF 4–6 mo
(n ¼ 213)
BF . 6 mo
(n ¼ 326) P Value
Child variables
Birth weight,† g 1,424 3,315 (557) 3,314 (516) 3,401 (553) 3,425 (491) 0.007
Gestational age,† wk 1,422 39.2 (1.7) 39.3 (1.7) 39.5 (1.6) 39.5 (1.5) 0.019
Age at spirometry,† yr 1,457 12.3 (1.2) 12.2 (1.2) 12.2 (1.2) 12.2 (1.2) 0.628
Height at spirometry,† cm 1,458 153 (9.7) 152 (10.3) 153 (10.0) 153 (10.0) 0.910
Weight at spirometry,† kg 1,458 47.3 (12.5) 45.8 (12.1) 45.4 (10.6) 45.6 (11.4) 0.093
Female‡ 1,458 214 (45.4) 217 (49.5) 106 (49.8) 145 (44.5) 0.539
Number of older siblings† 1,421 0.97 (1.00) 0.81 (0.94) 0.90 (0.87) 1.04 (1.04) 0.008
Nursery use‡ 1,445 178 (37.8) 185 (42.2) 108 (50.7) 147 (45.1) ,0.001
Wheezing during breastfeeding‡ 992 0 (0.0) 18 (4.3) 36 (14.5) 261 (20.2) ,0.001
Asthma history†,x 1,448 2.2 (3.5) 1.4 (2.5) 1.5 (2.8) 1.7 (3.3) 0.001
Frequency of colds†,k 1,436 1.7 (0.8) 1.6 (0.7) 1.8 (0.8) 1.7 (0.8) 0.085
Duration of colds†,¶ 1,427 0.9 (0.7) 0.8 (0.6) 0.8 (0.7) 0.8 (0.7) 0.098
Respiratory infections†,** 1,438 1.0 (1.0) 0.9 (1.0) 1.0 (1.0) 0.9 (1.0) 0.238
Positive SPT‡ 1,458 173 (36.7) 173 (39.5) 88 (41.3) 130 (39.9) 0.707
Family variables
Maternal age,† yr 1,457 28.89 (4.81) 29.21 (4.71) 30.67 (4.86) 31.39 (4.61) ,0.001
South Asian mother‡ 1,458 65 (13.8) 117 (26.7) 42 (19.7) 68 (20.9) ,0.001
High family education‡,†† 1,380 209 (44.4) 271 (61.9) 141 (66.2) 240 (73.6) ,0.001
Maternal asthma‡ 1,394 93 (19.7) 83 (18.9) 36 (16.9) 55 (16.9) 0.414
Paternal asthma‡ 1,355 96 (20.4) 72 (16.4) 43 (20.2) 64 (19.6) 0.030
Living in an affluent area‡,‡‡ 1,437 229 (48.6) 219 (50.0) 126 (59.2) 206 (63.2) 0.003
Urban residence‡ 1,458 246 (52.2) 244 (55.7) 106 (49.8) 154 (47.2) 0.062
Tobacco smoke exposures
Smoking during pregnancy‡ 1,422 106 (22.5) 47 (10.7) 12 (5.6) 19 (5.8) ,0.001
Smoking during childhood†,xx 1,458 1.34 (1.73) 1.02 (1.57) 0.73 (1.30) 0.69 (1.31) ,0.001
Definition of abbreviations: BF ¼ breastfeeding; SD ¼ standard deviation; SPT ¼ skin prick test.
Data are presented as number (%) or mean (SD), by duration of breastfeeding (N ¼ 1,458).
*Number of cases with complete data on each particular variable.
yNumeric covariates: values are mean (SD); analysis of variance test comparison.
zCategorical covariates: values are n (%), column percentages; chi-square test comparison.
xSum of four severity scores calculated at four data collection points as follows: 0 ¼ no current wheeze; 1 ¼ current wheeze, no treatment; 2 ¼ current wheeze 1
treatment with short-acting b-agonists only; 3 ¼ current wheeze 1 treatment with inhaled corticosteroids or montelukast; and 4 ¼ current wheeze 1 treatment with
steroid tablets.
kBased on a question from 1998 questionnaire: “In the last 12 months, how many times has your child had a cold or flu? (never, 1–3 times, 4–6 times, 7 or more
times)”. The variable was treated as numeric.
¶Based on a question from 1998 questionnaire: “How long does a cold usually last in your child? (less than 1 week; 1–2 weeks; 2–4 weeks; more than 4 weeks)”. The
variable was treated as numeric.
**Includes pneumonia, whooping cough, bronchiolitis, croup, throat infections, and other chest infections. The variable represents the sum.
yyHigher educational level attained by either parent, based on the British educational system: low ¼ none, General Certificate of Secondary Education (GCSE) or trade;
high ¼ A-levels, below degree, degree.
zzAbove median value of Townsend deprivation score, an area-based deprivation score (30).
xxEach family returned between two and four questionnaires before attending for measurements; the number represents the mean number of occasions when
maternal smoking was reported (see online supplement).
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FEF50. For forced midexpiratory flows, results were somewhat
different. Here, we found evidence for an increase of FEF50 with
increasing duration of breastfeeding in the entire sample, with
estimated differences in FEF50 of 0.130 L/s (P ¼ 0.048) and
0.164 L/s (P ¼ 0.041) for breastfeeding 4 to 6 months and
longer than 6 months, respectively, compared with those not
breastfed (Table 2 or Table E4, adjusted model, entire sam-
ple). These increases were greater in children of mothers with
asthma (estimated differences, 0.375 L/s [P ¼ 0.015] and 0.468
L/s [P ¼ 0.009] for breastfeeding 4–6 months and .6 months
compared with nonbreastfed) (Table E4, adjusted model, chil-
dren of mothers with asthma). The model including interaction
terms showed again evidence for lower FEF50 (estimated
difference, 20.175 L; P ¼ 0.040) in nonbreastfed children of
mothers with asthma compared with nonbreastfed children of
mothers without asthma. There was also evidence for higher
FEF50 in children of mothers with asthma breastfed for 4 months
or longer but limited evidence for an effect modification by ma-
ternal asthma (P interaction, 0.140 and 0.220 for breastfeeding
4–6 months and .6 months, respectively) (Figure 2, Table 3).
FEV1/FVC and PEF. There was no evidence of association be-
tween breastfeeding and PEF or FEV1/FVC. In children of moth-
ers with asthma, there was again a tendency for reduced values in
nonbreastfed children and higher values in breastfed children;
however, P values for associations and interaction terms did not
reach conventional significance thresholds.
TABLE 2. ASSOCIATION BETWEEN BREASTFEEDING DURATION AND LUNG FUNCTION IN THE
ENTIRE SAMPLE OF CHILDREN: BASELINE MODEL AND MODEL ADJUSTED FOR CONFOUNDERS
FVC, L FEV1, L FEV1/FVC PEF, L/s FEF50, L/s
Baseline model*
No BF† 2.838 2.531 0.891 5.587 3.402
BF < 3 mo 20.039 (0.116) 20.02 (0.356) 0.007 (0.064) 20.01 (0.865) 0.034 (0.479)
BF 4–6 mo 20.010 (0.758) 20.002 (0.949) 0.003 (0.446) 0.015 (0.839) 0.112 (0.061)
BF . 6 mo 0.024 (0.370) 0.025 (0.286) 0.002 (0.560) 0.077 (0.222) 0.116‡ (0.026)
Adjusted modelx
No BF* 2.835 2.528 0.892 5.621 3.386
BF < 3 mo 20.001 (0.970) 0.010 (0.653) 0.005 (0.195) 20.008 (0.889) 0.043 (0.395)
BF 4–6 mo 0.006 (0.849) 0.012 (0.674) 0.003 (0.503) 20.016 (0.838) 0.130‡ (0.048)
BF . 6 mo 0.035 (0.358) 0.041 (0.239) 0.004 (0.491) 0.004 (0.970) 0.164‡ (0.041)
Definition of abbreviations: BF ¼ breastfeeding; FEF50 ¼ forced midexpiratory flow; PEF ¼ peak expiratory flow.
Data are presented as unstandardized regression coefficient representing difference from reference category (P value).
*Adjusted for age, height, weight, sex, and quadratic terms for height and weight.
yReference category (intercept); the values represents the average lung function values in that category.
zP < 0.05.
xAdjusted for birth weight, gestational age, birth season (winter, spring, summer, autumn), age, height, weight, sex,
number of older siblings, nursery use, wheeze onset during breastfeeding, maternal age, maternal ethnicity, family edu-
cation, maternal asthma, paternal asthma, Townsend deprivation score (30), residence area (urban or rural), smoking
exposure during pregnancy, smoking exposure during childhood.
TABLE 3. ASSOCIATION BETWEEN MATERNAL ASTHMA, BREASTFEEDING DURATION, AND LUNG FUNCTION: ADJUSTED MODEL
WITH INTERACTION
FVC, L FEV1, L FEV1/FVC PEF, L/s FEF50, L/s
Nonbreastfed children
No maternal asthma* 2.851 2.547 0.894 5.639 3.421
Maternal asthma 20.080 (0.062) 20.095† (0.011) 20.010 (0.111) 20.091 (0.374) 20.175* (0.040)
Children of mothers without asthma (n ¼ 1,167)
No BF* 2.851 2.547 0.894 5.639 3.421
BF < 3 mo 20.018 (0.520) 20.001 (0.964) 0.005 (0.192) 20.026 (0.703) 0.024 (0.664)
BF 4–6 mo 20.022 (0.537) 20.019 (0.534) 0.001 (0.828) 20.055 (0.527) 0.086 (0.234)
BF . 6 mo 0.003 (0.932) 0.010 (0.795) 0.003 (0.656) 20.035 (0.723) 0.130 (0.125)
Children of mothers with asthma (interaction terms) (n ¼ 273)
No BF* 2.770 2.451 0.884 5.547 3.246
BF < 3 mo 0.063 (0.417) 0.051† (0.569) 0.002 (0.409) 0.056 (0.846) 0.111† (0.548)
Interaction‡ 0.081 (0.187) 0.052† (0.334) 20.003 (0.728) 0.082 (0.576) 0.086† (0.482)
BF 4–6 mo 0.123 (0.177) 0.148x (0.050) 0.013 (0.477) 0.149 (0.550) 0.319† (0.049)
Interaction‡ 0.145† (0.064) 0.167x (0.016) 0.011 (0.313) 0.204 (0.283) 0.234† (0.141)
BF . 6 mo 0.164† (0.040) 0.167x (0.016) 0.009 (0.645) 0.161 (0.490) 0.296† (0.061)
Interaction‡ 0.161† (0.018) 0.158x (0.008) 0.006 (0.531) 0.196 (0.233) 0.166† (0.224)
For definition of abbreviations, see Table 2.
Adjusted for age, height, weight, sex, quadratic terms for height and weight, birth weight, gestational age, birth season (winter, spring, summer, autumn), age,
height, weight, sex, number of older siblings, nursery use, wheeze onset during breastfeeding, maternal age, maternal ethnicity, family education, maternal asthma,
paternal asthma, Townsend deprivation score (30), residence area (urban or rural), smoking exposure during pregnancy, smoking exposure during childhood, and
interaction term between breastfeeding and maternal asthma.
*Reference category (intercept); the values represents the average lung function values in that category.
yP < 0.05.
zThe interaction term reflects the additional difference in children of mothers with asthma compared with the corresponding difference in children of mothers without
asthma, for a particular level of breastfeeding. For example, the difference in FVC between BF , 3 mo and no BF in children of mothers with asthma (0.063) equals the
corresponding difference in children of mothers without asthma (20.018) plus the interaction term (0.081). A model without interaction terms assumes that the
differences are equal in the two groups (children of mothers with asthma and mothers without asthma).
xP < 0.01.
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Additional Analyses
Our results remained similar after (a) analyzing only children with
complete data (no imputation; additional analysis 1a); (b) restricting
the analysis to children in whom breastfeeding had been assessed
at age 1 year, when recall is likely to be most accurate (additional
analysis 1b); (c) excluding from analysis children who had wheeze
onset during breastfeeding (first approach) and excluding all
children with wheeze onset during the first year of life (second
approach) to eliminate a possible bias due to reverse causation
(additional analysis 1c), and (d) analyzing prebronchodilator lung
function rather than post-bronchodilator outcomes (additional
analysis 1d) (Table E5–E7).
In a last step, we adjusted for alternative causal pathways,
which could help to explain our findings, by (a) adjusting for
frequency and severity of all respiratory infections in general
and lower respiratory tract infections in particular during the
first year of life, to assess whether the improved lung function in
breastfed children might be explained by reduced number or
severity of (lower) respiratory infections during infancy (addi-
tional analysis 2a); and (b) adjusting using separate variables for
manifestations of atopy, measured through skin prick tests, and
asthma history in the child, to assess whether the improved lung
function in breastfed children might be explained by a reduced
risk to develop atopy and/or asthma (additional analysis 2b).
Results of these two analyses were again similar to those of
the main analyses (Table E5–E7).
DISCUSSION
Findings
This study investigated the relationship between duration of
breastfeeding and lung function at school age in a cohort study
of children monitored since birth. Children breastfed for 4
months or longer had larger FEF50 at school age. Children of
mothers with asthma had larger FVC and FEV1 if they had been
breastfed, with evidence for a dose–response relationship with
duration of breastfeeding. Most importantly, there was no evi-
dence for a detrimental effect of breastfeeding in children
whose mothers had asthma. Results were not changed by ad-
justment for confounders and remained robust in numerous
additional analyses designed to evaluate potential biases related
to study population, assessment of breastfeeding and lung func-
tion, statistical analysis, and reverse causation.
Few studies have investigated the effect of breastfeeding on
lung function at school age (Tables E1 and E2). Associations
with FVC and FEV1 have been reported by several authors.
Guilbert and colleagues found in the Tucson Respiratory Co-
hort a larger FVC (1103 ml, P ¼ 0.010) in children breastfed for
longer than 4 months, but no evidence for an association with
FEV1 (6). Ogbuanu and colleagues reported, from the Isle of
Wight study, an increased FVC (154 ml, P ¼ 0.001) and FEV1
(139.5 ml, P ¼ 0.050) in 10-year-olds who had been breastfed
(9). From the same study, Soto-Ramı´rez and colleagues re-
ported, several years later, an increased FVC (11.48 ml/wk of
breastfeeding, P ¼ 0.01) and FEV1 (11.21 ml/wk of breastfeed-
ing, P ¼ 0.03) (10). Similarly, a higher FEV1 was reported for
breastfed children from affluent countries in the ISAAC study
(8), the Newcastle Thousand families study from the United
Kingdom (11), and the BAMSE cohort from Sweden (7). Overall,
these studies suggest a small but positive effect of breastfeeding.
Studies on PEF, FEF50, and FEV1/FVC were more hetero-
geneous. Kull and colleagues and Ogbuanu and colleagues re-
ported higher PEF in breastfed children (7, 9), two studies did
not report on flows (8, 11), and Guilbert and colleagues found
a negative association between breastfeeding and FEV1/FVC
ratio and forced expiratory flow between 25 and 75% of the
FVC (FEF25–75) (P ¼ 0.004 and 0.090, respectively) in the entire
group, which was particularly evident in children of mothers
with asthma (6). In our cohort, in contrast, there was little ev-
idence for an association between breastfeeding and PEF and
Figure 2. Adjusted mean values of lung function and 95% confidence intervals among children of mothers without asthma (n ¼ 1,167) and mothers
with asthma (n ¼ 273), categorized by duration of breastfeeding. This figure presents the results from the adjusted model with interaction term
between breastfeeding and maternal asthma. Adjusted for birth weight, gestational age, birth season (winter, spring, summer, autumn), age,
height, weight, sex, number of older siblings, nursery use, wheeze onset during breastfeeding, maternal age, maternal ethnicity, family education,
maternal asthma, paternal asthma, Townsend deprivation score, residence area (urban or rural), smoking exposure during pregnancy, smoking
exposure during childhood (see online supplement for description of variables). BF ¼ breastfeeding.
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FEV1/FVC. However, we found a higher FEF50 in breastfed children
in the entire group and in breastfed children of mothers with asthma.
The question of an effect modification by maternal asthma
remains controversial. Guilbert and colleagues concluded that
“. longer breastfed children of mothers with asthma demon-
strate no improved lung growth and significant decrease in air-
flows later in life” (6), making breastfeeding a potential hazard
for children of mothers with asthma. As potential mechanisms,
they suggested transmission of maternal IgE or other immuno-
logically active substances through breast milk. If confirmed,
these findings should lead to changes in feeding recommenda-
tions, making the topic highly relevant. However, the findings
from Tucson were not supported by a test for interaction and
were not replicated by other cohorts (7–9). Our results further
help to remove concerns that breastfeeding might harm chil-
dren of mothers with asthma. We found no evidence for an
effect modification by maternal asthma on midexpiratory flows,
whereas FVC and FEV1 were significantly higher rather than
lower in breastfed children of mothers with asthma. It is unclear
why our results differ from those from Tucson. Possible explan-
ations include chance, differences in confounders used in the
analysis, or a bias such as reverse causation. They could, how-
ever, also reflect real differences between the two studies. For
instance, if mothers with asthma in Tucson had been treated
with oral steroids or high-dose bronchodilators, these drugs,
transmitted through breast milk, might have influenced fetal
lung development and thus later airway function. Note also that
the design of the Tucson study differed from ours; they looked
at lung function at two points in time, at 11 and 16 years, using
a longitudinal random-effects model. The Tucson study also
reported an effect in children of mothers who were atopic but
did not have asthma. We performed a separate analysis using
maternal history of hayfever instead of asthma as predictor/
effect modifier, but we did not find evidence for differences in
the association between breastfeeding and lung function by ma-
ternal history of hayfever (results not reported). This suggests
that maternal asthma, rather than atopy, is responsible for the
differential effect in children of affected mothers.
Possible Mechanisms or Pathways
There are several mechanisms by which breastfeeding might in-
fluence lung function in children. These include: (1) reducing the
frequency and severity of viral infections during infancy through
transmission of maternal IgA or other immunological agents via
breast milk (3), resulting in less virus-induced lung damage (20);
and (2) reducing the risk of atopy, asthma, or reactive airway
disease in the child (21). These two mechanisms might interact,
although the literature on this issue is unclear (22). Finally, (3)
breastfeeding might directly influence lung development by
transmission of relevant cytokines or maternal hormones (23),
which stimulate alveolarization (24–26) or airway growth or, as
suggested by the researchers from the Isle of Wight study, by
mechanical stimuli related to suckling (9, 10).
In our study, we examined whether these mechanisms ac-
count for the better lung function observed in breastfed children
by including into our analysis a number of relevant variables re-
lated to these pathways. If the effect was mediated via one of
these mechanisms, we would expect the effect of breastfeeding
to decrease when the variables were included into the equation.
This was not the case, suggesting, at least partially, a direct effect
of breastfeeding on lung growth and structure. This is also
supported by the fact that we found the association both in
post-bronchodilator and prebronchodilator lung function. The
ISAAC study also reported an effect of breastfeeding on lung
function but not on bronchial hyperresponsiveness (8).
When we stratified the analysis for maternal asthma, our find-
ings were more complex. Children who had not been breastfed
had lower FVC, FEV1, and FEF50 if their mothers had asthma.
Breastfeeding was associated with a better FVC and FEV1 in
children of mothers with asthma and with a better FEF50 in all
children (independent of maternal asthma).
It is not clear why an effect of breastfeeding should differ be-
tween children of mothers with asthma and children of mothers
without asthma; we can only speculate on the mechanisms. One
possible explanation is that mothers with asthma have more
frequent or more severe respiratory infections, which they could
pass on to their infants (27, 28). If these infections are not
tempered by breastfeeding, they could lead to poorer lung de-
velopment and lung function. However, in the additional anal-
ysis we did not find a mediating effect of early infections. It is
possible that the mechanisms are more complex so that their
effect could not be captured in our model and/or that there are
other possible explanations. For instance, children of mothers
with asthma might have a genetic or epigenetic susceptibility to
poor lung growth that could interact with breastfeeding. The
question remains open.
Strengths and Limitations
This study has a number of strengths: it used data from a large
representative cohort with short recall time for breastfeeding
and prospective assessment of other exposures and respiratory
outcomes. We included a large number of potential confounders
in the analysis and we tested the robustness of our results with
a number of additional analyses, looking at the effect of missing
data, recall bias, and reverse causation. Limitations include the
modest response rate for the laboratory examinations (36%),
which has reduced power and could potentially have introduced
bias. The most likely explanation for the low participation is that
many potential participants were discouraged because they ex-
pected a lengthy and time-consuming procedure. The number of
appointments that could be offered during school holiday times
were limited, and many parents are reluctant to take their chil-
dren away from school. However, this response rate is not
unusual for laboratory measurements in a population-based co-
hort. The sample analyzed might not be fully representative of
the entire population of the Leicestershire area. The results from
the participants/nonparticipants comparison analysis (Table E3)
suggest that the participants tended to come from a higher socio-
economic class. Similarly, breastfeeding prevalence in our sam-
ple differed slightly from the prevalence in the Leicestershire
area (29), with proportionally more children being breastfed
in our sample. This, however, should not affect the association
between breastfeeding duration and lung function measure-
ments. As in other studies (6, 9), we relied on self-reported
duration of breastfeeding, maternal asthma, and infections
during infancy. The repeatability of the question on duration
of breastfeeding in this cohort was excellent (Cohen’s kappa,
0.96), suggesting high validity of this information (19). There
was also a potential risk for recall bias for the age of wheezing
onset. The sensitivity analysis in children who were 1 year old at
recruitment yielded comparable results; therefore, we are con-
fident that our findings are robust.
Relevance of the Findings
The mean differences in lung function detected in this study be-
tween breastfed and nonbreastfed children are not very relevant,
clinically, for healthy children. However, if we consider the num-
ber of children falling below a certain lung function threshold
rather than a shift in mean values, our findings become relevant
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at population level. For instance, if we take as threshold the value
of the 20th percentile of lung function (adjusted for age, sex,
height, and weight) among nonbreastfed children of mothers
with asthma, and assuming that breastfeeding causes a shift in
the Gaussian distribution of FVC (FEV1) by 165 ml (168 ml),
as estimated in our study, then the number of children falling
below the threshold would decrease from 20 to 9%. These
reductions are important at a population level. These children
with lower FVC or FEV1 as young adults might be more at risk
of developing chronic obstructive pulmonary disease later in life.
Conclusions
In conclusion, this study adds importantly to existing evidence
against claims that breastfeeding could be harmful in children
of mothers with asthma. In contrast, it suggests a modest im-
provement in midexpiratory flows in all children, and in FVC
and FEV1 in the offspring of mothers with asthma. Our data
suggest that, rather than acting via reduction of respiratory
infections, asthma, or allergy, breastfeeding might have a direct
effect on lung growth, which should be investigated further. In
the meantime, breastfeeding can remain strongly recommended
for all infants, including those whose mothers have asthma.
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